-Bloomberg At Cantor Fitzgerald Event
Related Posts
Roth Capital Maintains Buy on Syros Pharmaceuticals, Raises Price Target to $23
Roth Capital analyst Zegbeh Jallah maintains Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and raises the price target from $20 to $23.
DA Davidson Maintains Buy on Best Buy Co, Raises Price Target to $110
DA Davidson analyst Michael Baker maintains Best Buy Co (NYSE:BBY) with a Buy and raises the price target from $107 to $110.
AZZ, Leggett & Platt And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: